Your browser doesn't support javascript.
loading
The clinical effectiveness of pegylated interferon and ribavirin for the treatment of chronic hepatitis C in HIV-infected patients in Brazil: a multicentric study
Ferreira, Paulo Roberto Abrão; Silva, Mariliza Henrique da; Brandão-Melo, Carlos Eduardo; Rezende, Rosamar Eulira; Gonzalez, Mário; Reuter, Tânia; Urbaez, Jose David; Gianini, Reinaldo Jose; Martinelli, Ana; Mendes-Correa, Maria Cássia.
Afiliação
  • Ferreira, Paulo Roberto Abrão; Universidade Federal de São Paulo. São Paulo. BR
  • Silva, Mariliza Henrique da; Universidade Federal de São Paulo. São Paulo. BR
  • Brandão-Melo, Carlos Eduardo; Universidade Federal de São Paulo. São Paulo. BR
  • Rezende, Rosamar Eulira; Universidade Federal de São Paulo. São Paulo. BR
  • Gonzalez, Mário; Universidade Federal de São Paulo. São Paulo. BR
  • Reuter, Tânia; Universidade Federal de São Paulo. São Paulo. BR
  • Urbaez, Jose David; Universidade Federal de São Paulo. São Paulo. BR
  • Gianini, Reinaldo Jose; Universidade Federal de São Paulo. São Paulo. BR
  • Martinelli, Ana; Universidade Federal de São Paulo. São Paulo. BR
  • Mendes-Correa, Maria Cássia; Universidade Federal de São Paulo. São Paulo. BR
Braz. j. infect. dis ; 19(1): 15-22, Jan-Feb/2015. tab
Artigo em Inglês | LILACS | ID: lil-741237
Biblioteca responsável: BR1.1
ABSTRACT

Introduction:

in Brazil, chronic hepatitis C in patients coinfected with the human immunodeficiency virus (HIV) is treated with pegylated interferon (Peg-IFN) and ribavirin (RBV). However, few studies have evaluated the effectiveness of this treatment in this particular population. The identification of the factors that predict sustained virological response (SVR) under current clinical practice would enable clinicians to more accurately estimate the probability of achieving an SVR and therefore utilize the appropriate therapeutics, especially in the era of direct-acting antiviral (DAA) agents.

Aims:

the primary aim of our study was to determine the SVR rate under current clinical practice. The secondary aims were as follows (1) to determine the factors before and during treatment that predict SVR; and (2) to identify the causes of treatment interruption.

Methods:

within a cohort of HIV/hepatitis C virus (HCV)-coinfected patients in Brazil, we performed a retrospective analysis of those individuals treated with Peg-IFN and RBV.

Results:

among the 382 analyzed patients, SVR was observed in 118 [30.9% (95% confidence interval (CI) 26.3-35.8)], which included 25.9% (75/289) of the patients with genotypes 1 and 4 and 48.2% (41/85) of those with genotypes 2 and 3. After multivariate analyses the independent positive predictors for SVR after treatment for chronic hepatitis C with PegIFN and RBV were absence of an AIDS-defining illness (p = 0.001), HCV viral load lower than 600,000 IU/mL at the onset of treatment (p = 0.003), higher liver enzyme levels (p = 0.039) at baseline, infection with genotypes 2 or 3 (p = 0.003), and no transient treatment interruption (p = 0.001). The treatment was interrupted in 25.6% (98/382) of the patients because of adverse events (11.3%, 43/382), virologic failure (7.8%, 30/382), and dropout (6.5%, 43/382). The main adverse events were cytopenia and psychiatric disorders.

Conclusions:

...
Assuntos

Texto completo: Disponível Base de dados: LILACS Assunto: Antivirais / Polietilenoglicóis / Ribavirina / Interferon-alfa / Hepatite C Crônica Tipo de estudo: Estudo de etiologia / Estudo de incidência / Estudo observacional / Estudo prognóstico / Fatores de risco Limite: Adulto / Feminino / Humanos / Masculino País/Região como assunto: América do Sul / Brasil Idioma: Inglês Revista: Braz. j. infect. dis Ano de publicação: 2015 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponível Base de dados: LILACS Assunto: Antivirais / Polietilenoglicóis / Ribavirina / Interferon-alfa / Hepatite C Crônica Tipo de estudo: Estudo de etiologia / Estudo de incidência / Estudo observacional / Estudo prognóstico / Fatores de risco Limite: Adulto / Feminino / Humanos / Masculino País/Região como assunto: América do Sul / Brasil Idioma: Inglês Revista: Braz. j. infect. dis Ano de publicação: 2015 Tipo de documento: Artigo